ModMed has acquired Bonsai Health, adding an agentic AI patient engagement platform to its specialty practice software stack. The deal extends ModMed’s push to build what it calls the AI-Powered Practice, a strategy aimed at automating more of the front office for medical groups that still rely heavily on manual outreach, scheduling and reactivation workflows.
The strategic logic is straightforward. Specialty practices lose revenue when patients drift out of care and schedules go unfilled. Staff are expensive, turnover is high and call centers do not scale cleanly. Bonsai’s software is designed to identify care gaps, detect open slots and then use SMS and email to re-engage patients and book appointments without staff intervention. That makes it a direct operational tool, not just another communications layer.
ModMed already sells patient engagement tools through Klara, which functions more like a centralized communication hub. Bonsai adds a more proactive automation engine. Together, the products point to a broader consolidation trend in healthcare software, where vendors are trying to own more of the workflow rather than sell point solutions that sit on the edge of the system. Who controls the patient touchpoint controls a growing share of the economics.
The acquisition also reflects the value of domain-specific AI in healthcare. Bonsai is led by Travis Schneider and Luke Kervin, who previously co-founded PatientPop, giving the business credibility in a market that has seen plenty of generic automation claims and uneven execution. For ModMed, the appeal is scale. The company says Bonsai will be rolled out across nearly 50,000 providers in specialties including dermatology, ophthalmology, orthopedics, gastroenterology and ENT.
For Clearlake Capital, ModMed’s backer, the transaction fits a familiar private equity playbook. Add capability, deepen platform stickiness and increase cross-sell into an installed base. The macro backdrop helps too. Healthcare providers are under pressure to do more with fewer administrative staff, and software that can automate patient outreach and improve schedule utilization has a clear economic case. The question now is execution. Can ModMed turn AI from a feature into a measurable operating advantage?
Source: Company press release and Acquire.fyi's proprietary data
